1. Abrams P, Kelleher CJ, Kerr LA, et al. Overactive bladder significantly affect
quality of life. Am J Manag;6 (Suppl 11):58090. 2000
2. Coyne KS, Sexton CC, Irwin DE, et al. The impact of overactive bladder,
incontinence and other lower urinary tract symptoms on quality of life, work
productivity, sexuality and emotional wellbeing in men and women. BJU
International: 2008.
3. Irwin DE, Mungapen L, Milsom I, et al. The economic impact of overactive
bladder syndrome in six Western countries. BJU International: 2009.
4. Parsons KJ. Benign Prostatic Hyperplasia and Male Lower Urinary Tract
Symptoms: Epidemiology and Risk Factor. PMC: 2010.
7. Presti, J. C., et al. Neoplasm of The Prostate Gland. In : Tanagho, Emil A.,
Jack W. McAnich, ed. Smith’s General Urology 17th Ed. USA : The cGraw
Hill Companies Inc. 2008.
8. Kidingallo Y, Murtala B, Ilyas M, Palinrungi AM. Kesesuaian ultrasonografi
transabdominal dan transrektal pada penentuan karakteristik pembesaran
prostat. JST Kesehatan. 1(2): 158−164. 2011.
9. Schauer IG, Rowley DR. The functional role of reactive stroma in benign
prostatic hyperplasia. NIH Public Access. 82(4): 200−210. 2012.
10. Purnomo. Dasardasar urologi. Edisi ke3. Jakarta: Sagung Seto. 2012
11. Yoo TK, Cho HJ. Benign prostatic hyperplasia: from bench to clinic. Korean
Jurnal of Urology. 53(3): 139−148. 2012.
13. Nicholson TM, Ricke WA. Androgens and estrogens in benign prostatic
hyperplasia: past, present and future. NIH Public Access. 82(4): 184−199.
2012.
14. Kumar V, Cotran RS, Robbins SL. Buku ajar patologi Robbins. Edisi ke7.
Jakarta: EGC. 2007.
15. Saputra L. Harrison manual kedokteran. Tangerang: Karisma. 2009.
19. Muhartono, Fiana DN, Kurrahman GN. Efek perlindungan madu terhadap
kerusakan lambung tikus yang diberi etanol. Medical Journal of Lampung
University. 1(2): 52−62. 2013.
20. Katzung BG. Farmakologi dasar dan klinik. Edisi ke10. Jakarta: EGC. 2012.
21. Fujiwara A, Nakahira J, Sawai T, Inamoto T, Minami T. Prediction of clinical
manifestations of transurethral resection syndrome by preoperative
ultrasonographic estimation of prostate weight. Journal of BMC Urology.
14(67): 1−6. 2014.
22. Lee YT, Ryu YW, Lee DM, Park SW, Yum SH, Han JH. Comparative
analysis of the efficacy and safety of conventional transurethral resection of
the prostate, transurethral resection of the prostate in saline (TURIS), and
TURISplasma vaporization for the treatment of benign prostatic hyperplasia:
a pilot study. Korean Journal of Urology. 52(11): 763−768. 2011.
23. Izumi K, Mizokami A, Lin WJ, Lai KP, Chang C. Androgen receptor roles in
the development of benign prostate hyperplasia. The American Journal of
Pathology. 182(6): 1942−1949. 2013.
24. Junqueira LC, Carneiro C. Histologi dasar: teks dan atlas. Edisi ke10.
Jakarta: EGC. 2007.
26. Lai KP, Huang CK, Fang LY, Izumi K, Lo CW, Wood R. Targeting stromal
androgen receptor suppresses prolactindriven benign prostatic hyperplasia
(BPH). Journal of Molecular Endocrinology. 27(10): 1617 −1631. 2013.
27. Moore KL, Agur AMR. Anatomi klinik dasar. Jakarta: Hipokrates. 2002.
28. Sherwood L. Fisiologi manusia; dari sel ke sistem. Edisi ke6. Jakarta: EGC.
2012.